| Main Title |
National emission standards for hazardous air pollutants (NESHAP) for the pharmaceutical manufacturing industry : background information for promulgated standards, summary of public comments and responses / |
| CORP Author |
Environmental Protection Agency, Research Triangle Park, NC. Office of Air Quality Planning and Standards. |
| Publisher |
U.S. Environmental Protection Agency, Office of Air Quality Planning and Standards, |
| Year Published |
1998 |
| Report Number |
EPA-453/R-98-002 |
| Stock Number |
PB99-158628 |
| OCLC Number |
42084868 |
| Subjects |
Pharmaceutical industry--Environmental aspects--United States ;
Air quality--Standards--United States
|
| Additional Subjects |
Drug industry ;
Air pollution standards ;
Standards compliance ;
Air pollution sources ;
Air pollution control ;
Clean Air Act ;
Pollution regulations ;
Emissions ;
Industrial plants ;
Waste water treatment ;
Leaks ;
Equipment ;
Storage tanks ;
Vents ;
Monitoring ;
Requirements ;
Record keeping ;
Public comments ;
Responses ;
NESHAP(National Emission Stnadards for Hazardous Air Pollutants) ;
National Emission Standards for Hazardous Air Pollutants ;
Pharmaceutical manufacturing ;
MACT(Maximum Achievable Control Technology) ;
New Source Performance Sources ;
Pollution prevention
|
| Internet Access |
|
| Holdings |
| Library |
Call Number |
Additional Info |
Location |
Last
Modified |
Checkout
Status |
| EHAM |
EPA/453-R-98-002 |
|
Region 1 Library/Boston,MA |
12/30/1999 |
| EKBD |
EPA-453/R-98-002 |
|
Research Triangle Park Library/RTP, NC |
10/08/1999 |
| ELBD ARCHIVE |
EPA 453-R-98-002 |
Received from HQ |
AWBERC Library/Cincinnati,OH |
10/04/2023 |
DISPERSAL |
| ERAD |
EPA 453/R-98-002 |
|
Region 9 Library/San Francisco,CA |
08/27/1999 |
| ESAD |
EPA-453-R-98-002 |
|
Region 10 Library/Seattle,WA |
08/27/1999 |
| NTIS |
PB99-158628 |
Some EPA libraries have a fiche copy filed under the call number shown. |
|
07/26/2022 |
|
| Collation |
1 v. (various pagings) ; 28 cm. |
| Abstract |
Clean Air Act as amended in 1990. Public comments were received from 46 sources consisting mainly of States, pharmaceutical manufacturers, industry trade associations, environmental groups, and other interested parties. All of the comments that were submitted and the responses to these comments are summarized in this document. This summary is the basis for the revisions made to the standards between proposal and promulgation. |
| Notes |
"July 1998." Written on cover: EPA-453/R-98-002. |
